• Health & Medicine

Mixing complementary therapy with standard cancer treatment could affect survival

A new study explores the impact that mixing complementary therapy with conventional cancer treatment can have on survival. A new study explores the impact that mixing complementary therapy with conventional cancer treatment can have on survival.

20 July 2018

• Health & Medicine

Older people and cancer: how research could personalise treatment plans and care

We look at how research could help to adapt and improve treatment for older patients, including inclusive clinical trials and pre-habilitation. We look at how research could help to adapt and improve treatment for older patients, including inclusive clinical trials and pre-habilitation.

16 July 2018

• Health & Medicine

Life-extending immunotherapy approved on NHS for children with neuroblastoma

Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life. Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.

13 July 2018

• Science & Technology

Exploiting the brain tumour environment to make better treatments

Brain tumours are heavily influenced by their surroundings so understanding the environment they’re in could reveal ways to destroy them. Brain tumours are heavily influenced by their surroundings so understanding the environment they’re in could reveal ways to destroy them.

12 July 2018

• Science & Technology

Cell ‘chatter’ discovery could open clinical trial opportunity for fatal childhood brain tumour

DIPG is a fatal childhood brain tumour. But our scientists are unpicking its biology in the hope of finding new ways to tackle this hard to treat cancer. DIPG is a fatal childhood brain tumour. But our scientists are unpicking its biology in the hope of finding new ways to tackle this hard to treat cancer.

2 July 2018

• Science & Technology

Unlocking new insight into brain tumours using neuroscience

From targeting cancer stem cells to reawakening sleeping cells, research is finding the answers to how brain tumours develop. From targeting cancer stem cells to reawakening sleeping cells, research is finding the answers to how brain tumours develop.

28 June 2018

• Health & Medicine

Drug could protect children from hearing loss after chemo

New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin.

20 June 2018

• Health & Medicine

New drug halves hearing loss in children following cancer treatment

Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research. Giving the drug sodium thiosulphate after chemotherapy reduces hearing loss in children treated for liver cancer, according to new research.

20 June 2018

• Health & Medicine

Cancer Research UK tests first of its kind vaccine to treat lung cancer

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer. A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

12 June 2018

• Health & Medicine

Combining heartburn drugs and aspirin could help prevent oesophageal cancer in people at high risk

Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease. Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease.

4 June 2018

• Health & Medicine

Chemoradiotherapy before surgery may extend lives of pancreatic cancer patients

Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery. Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery.

4 June 2018

• Health & Medicine

Taking aspirin and anti-acid reflux medication prevents oesophageal cancer in high risk patients

Taking an anti-acid reflux medication together with a low dose of aspirin can prevent oesophageal cancer in people with a high risk of the disease. Taking an anti-acid reflux medication together with a low dose of aspirin can prevent oesophageal cancer in people with a high risk of the disease.

4 June 2018